All articles

Losing weight with hypothyroidism can be perceived as more difficult, even with healthy lifestyle habits. An underactive thyroid means lower levels of hormones that regulate metabolism, which can affect energy expenditure and stamina. However, the effect on body weight is usually moderate and varies between individuals. When hypothyroidism is treated and hormone levels normalize, the conditions for weight loss improve.

Understanding why the body does not always respond as expected to diet and physical activity is an important starting point for the right treatment. Lipedema and overweight can in some cases resemble each other, but are two different conditions with distinct underlying mechanisms. They can also occur simultaneously, which can further complicate the clinical picture.

The demand for medical treatment of obesity and overweight has increased significantly in recent times, which in turn has contributed to the emergence of a market where medicines are sometimes distributed outside established and regulated healthcare systems. Using these medications without a doctor's prescription, and without structured and continuous follow-up, entails significant medical risks.

Body Mass Index (BMI) is one of the most widely used screening tools in healthcare for estimating the relationship between body weight and height. The measurement provides a general, statistical starting point for assessing the risk of various health conditions. At the same time, it is important to emphasize that BMI has limitations and cannot alone provide a complete picture of an individual's health status on its own.

Managing overweight is rarely a matter of willpower. The body's complex biological systems interact to regulate appetite, energy expenditure, and fat storage – often in a way that counteracts weight loss. Medical weight loss aims to influence these processes and create better conditions for sustainable results over time. Here, we go through how the medications work and who the treatment is suitable for.

CagriSema is a drug treatment under development for obesity. It combines two active substances, semaglutide and cagrilintide. By integrating two hormonal mechanisms of action, the treatment aims to influence both appetite regulation and glucose metabolism more comprehensively than treatment with a single substance.

Interest in new drug treatments for obesity has increased markedly in recent years. MariTide is a treatment under clinical development that could potentially contribute to an increased understanding of the body's weight regulation and broaden treatment options for obesity.

Learn how to eat nutritiously and save money with evidence-based tips from our dietitians. Discover how weight loss medication impacts your food budget and start your journey today.

KwikPen is a pre-filled multi-dose pen from the pharmaceutical company Eli Lilly, used to administer the medication Mounjaro. This type of pen is designed to facilitate regular dosing during medical weight loss and the treatment of type 2 diabetes. Here we go through how to handle the pen safely – from preparation to correct storage – to ensure your treatment works optimally.

A protein-rich salmon bowl is a nutrient-dense meal that can actively support your weight loss by keeping you full, stabilising blood sugar, and preserving your vital muscle mass. By combining omega-3-rich salmon with fibre-rich vegetables, edamame beans, and whole grains, you create a balanced bowl that is both nutrient-dense and protein-rich. This guide explains exactly why these ingredients are optimal for your health, how to prepare the meal effectively for the week's lunch boxes, and the profound benefits the dish provides for your body.

‍

Orforglipron is an oral (non-peptide) GLP-1 receptor agonist that was recently approved in the USA (under the name Foundayo) for the treatment of adults with obesity or overweight with at least one weight-related comorbidity. In clinical studies, the treatment has shown efficacy in both weight loss and blood sugar control.

The choice between bariatric surgery and medical treatment has changed alongside the development of new, effective medications. Today, modern GLP-1 and GLP-1/GIP receptor agonists can provide significant weight loss that, in some cases, approaches the results previously achieved primarily through bariatric surgery. Here, we look at both options from a medical perspective and describe their effects, risks, and benefits.

Not losing weight despite feeling like you are doing "everything right" is rarely due to a lack of discipline. The body's biology and hormonal systems play a central role in regulating body weight and can counteract weight loss.

To achieve sustainable results, it can therefore be valuable to understand how appetite regulation and individual circumstances affect weight, as well as which evidence-based treatment options are available.

Semaglutide and tirzepatide are both well-documented medications for medical weight loss. In clinical studies, tirzepatide has shown a greater average weight loss than semaglutide, but individual efficacy, tolerability, and treatment choices vary. The choice of treatment should always be based on an individual medical assessment.

New data proves sustainable weight loss delivers significant savings for patients.

‍
A pan-European survey of 1,350+ Yazen patients reveals a "health dividend" where effective obesity treatment offsets its own cost. By addressing biological cravings, patients save an average of €109 on food and €50 on healthcare monthly. Findings show a natural shift away from snacks and takeaways toward nutrient-dense, mindful consumption.

The concept of the “Golden dose” for Mounjaro refers to the residual liquid that may remain in a KwikPen after the intended doses. Advice on using this as an extra dose is spreading on social media, but healthcare providers advise against it because the dose is not quality-assured. Extracting residual liquid can lead to incorrect dosing and increased risk of side effects. Changes in how the medication is provided aim to strengthen patient safety.

The term “Golden dose” refers to the residual liquid that may remain in a Wegovy pen after the intended doses. Advice on using this as an extra dose is spreading on social media, but healthcare providers clearly advise against this. There is a risk of incorrect dosing as well as a risk of contamination when manipulating the pen outside of its intended use.

To obtain Ozempic, a medical assessment by a licensed doctor is required. GLP-1 analogues have revolutionized weight loss, but high demand creates questions regarding regulations and safety. Many wonder about the requirements for prescriptions and the risks of online orders. This guide explains the process within the EU and patient requirements. It is crucial to choose a regulated healthcare provider like Yazen to guarantee safe treatment and avoid unreliable sources.

Many who struggle with their weight wonder if a low metabolism could be an explanation. In practice, there are usually several underlying causes for weight challenges, where metabolism is one of several factors. Metabolism plays a central role in how the body uses energy, but the connection between low metabolism, weight, and diet is often more complex than one might think.

Wondering what you should weigh at your age? Many people look for weight charts to find an ideal weight, but a healthy weight cannot be determined solely by your age or height. Body composition, muscle mass and where fat is stored are often far more important than the number on the scale. Read what science says about age, BMI and how to find your unique healthy weight.

When can I reach my goal weight? It’s one of the most common questions during a weight loss journey. The answer depends on your starting weight, your biology, your height, your body composition and how your body responds to treatment. Losing weight is a process that takes time and is rarely linear. Here, we explain what affects the pace, why a goal weight is more of a direction than a fixed number, and how Yazen supports you along the way.

Are you worried about developing "Wegovy face" during your medical weight loss journey? This term describes the hollow or sagging facial appearance that can occur after rapid weight loss. It is a natural result of losing subcutaneous fat, not a direct side effect of the medication itself. Discover why your face changes during weight loss and how you can support skin health.

‍

Combining physical activity with your medical treatment is one of the best ways to achieve sustainable health and effective weight management. While modern treatments are highly effective, exercising protects your muscle mass, supports bone health, and boosts long-term results. Discover how to safely exercise on weight loss medication, which workouts are most effective, and how the Yazen team can support your active lifestyle.

‍

Are you wondering if you can drink alcohol while taking GLP-1 medication? The short answer is yes, but you’ll need to be careful. Medicines like Wegovy and Mounjaro can change how your body processes both food and alcohol. This can increase side effects like nausea and affect your alcohol tolerance. Here are a few things to help you make safe, informed choices.

‍

‍